• English
  • 简体中文
Login Register
Current Location: Home > Feedback Help Print

【结 构 式】

【分子编号】61580

【品名】N-Benzoylcytidine;N-[1-[3,4-Dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-2-oxopyrimidin-4-yl]benzamide;N-{1-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)tetrahydro-2-furanyl]-2-oxo-1,2-dihydro-4-pyrimidinyl}benzamide

【CA登记号】13089-48-0

【 分 子 式 】C16H17N3O6

【 分 子 量 】347.3276

【元素组成】C 55.33% H 4.93% N 12.1% O 27.64%

与该中间体有关的原料药合成路线共 3 条

合成路线1

该中间体在本合成路线中的序号:(XIII)

Reaction of cytidine (XII) with benzoyl anhydride in DMF gives Nbenzoylcytidine (XIII), which is selectively protected with 1,3-dichloro-1,1,3,3-tetraisopropyldisiloxane (TIPDSCl2) in pyridine to yield the silylated cytidine (XIV). Oxidation of the remaining OH group of (XIV) by means of DMSO, TFAA and TEA produces the ketone (XV), which by a Grignard condensation with MeLi, followed by a desilylation with AcOH provides the tertiary alcohol (XVI). Selective benzoylation of the primary and secondary OH groups of compound (XVI) with benzoyl chloride and pyridine results in tribenzoate (XVII) with a remaining free tertiary OH group. Finally, benzoate (XVII) is fluorinated with DAST to yield the tribenzoylated fluorocytidine (II) .

1 Clark, J. (Pharmasset, Inc.). Modified fluorinated nucleoside analogues, WO 2005003147.
2 Clark, J.L., Hollecker, L., Mason, J.C. et al. Design, synthesis, and antiviral activity of 2’-deoxy-2’-fluoro-2’-C-methylcytidine, a potent inhibitor of hepatitis C virus replication. J Med Chem 2005, 45(17): 5504-8.
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(XVII) 65909 N-Benzoyl-3',5'-di-O-benzoyl-2'-C-methyl-D-cytidine   C31H27N3O8 详情 详情
(II) 65910 (2'R)-N-Benzoyl-2'-deoxy-2'-fluoro-2'-methylcytidine 3',5'-dibenzoate 817204-32-3 C31H26FN3O7 详情 详情
(XII) 27920 Cytidine; 4-amino-1-((2S,3S,4S,5S)-3,4-dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)pyrimidin-2(1H)-one;4-amino-1-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)tetrahydro-2-furanyl]-2(1H)-pyrimidinone 65-46-3 C9H13N3O5 详情 详情
(XIII) 61580 N-Benzoylcytidine;N-[1-[3,4-Dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-2-oxopyrimidin-4-yl]benzamide;N-{1-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)tetrahydro-2-furanyl]-2-oxo-1,2-dihydro-4-pyrimidinyl}benzamide 13089-48-0 C16H17N3O6 详情 详情
(XIV) 65906 N-Benzoyl-3',5'-O-[1,1,3,3-tetrakis(1-methylethyl)-1,3-disiloxanediyl]cytidine; N-[1-[(6aR,8R,9R,9aS)-9-hydroxy-2,2,4,4-tetra(propan-2-yl)-6a,8,9,9a-tetrahydro-6H-furo[3,2-f][1,3,5,2,4]trioxadisilocin-8-yl]-2-oxopyrimidin-4-yl]benzamide 69304-43-4 C28H43N3O7Si2 详情 详情
(XV) 65907 N-Benzoyl-2'-deoxy-2'-oxo-3',5'-O-[1,1,3,3-tetrakis(1-methylethyl)-1,3-disiloxanediyl]cytidine 119411-03-9 C28H41N3O7Si2 详情 详情
(XVI) 65908 N-Benzoyl-2'-C-methyl-D-cytidine   C17H19N3O6 详情 详情

合成路线2

该中间体在本合成路线中的序号:(II)

The reaction of cytidine (I) with benzoyl anhydride in dioxane gives N-benzoylcytidine (II), which is selectively monoprotected at the primary OH group by means of 4-methoxytrityl chloride and pyridine to yield N-benzoyl-5'O-(monomethoxytrityl)cytidine (III). The monosilylation of (III) by means of Tbdms-Cl and AgNO3 in pyridine/THF affords a mixture of the 3'-O-silyl (IV) and the desired 2'-O-silyl (V) derivative which is easily separated by flash chromatography. (The yield of the desired 2'-O-silyl isomer (V) can be improved by isomerization of the 3'-O-silyl isomer (IV) by means of pyridine in methanol at 70 C). The oxidation of (V) by means of CrO3 and Ac2O provides the 3'-oxonucleoside (VI), which is selectively deprotected by means of TsOH in chloroform/methanol to give compound (VII). The reaction of (VII) with trimethylsilylacetylene (VIII) by means of BuLi and CeCl3 in THF yields the protected ethynyl nucleoside (IX), which is debenzoylated by means of NH3 in methanol to afford the silylated nucleoside (X). Finally, this compound is treated with TBAF in THF to obtain the target ethynyl cytidine.

1 Ludwig, P.S.; Schwender, R.A.; Schott, H.; A new laboratory scale synthesis for the anticancer drug 3'-C.ethynylcytidine. Synthesis (Stuttgart) 2002, 16, 2387.
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(I) 27920 Cytidine; 4-amino-1-((2S,3S,4S,5S)-3,4-dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)pyrimidin-2(1H)-one;4-amino-1-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)tetrahydro-2-furanyl]-2(1H)-pyrimidinone 65-46-3 C9H13N3O5 详情 详情
(II) 61580 N-Benzoylcytidine;N-[1-[3,4-Dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-2-oxopyrimidin-4-yl]benzamide;N-{1-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)tetrahydro-2-furanyl]-2-oxo-1,2-dihydro-4-pyrimidinyl}benzamide 13089-48-0 C16H17N3O6 详情 详情
(III) 61581 N-[1-((2R,3R,4S,5R)-3,4-dihydroxy-5-{[tris(4-methoxyphenyl)methoxy]methyl}tetrahydro-2-furanyl)-2-oxo-1,2-dihydro-4-pyrimidinyl]benzamide C38H37N3O9 详情 详情
(IV) 61582 N-[1-((2R,3R,4S,5R)-4-{[tert-butyl(dimethyl)silyl]oxy}-3-hydroxy-5-{[tris(4-methoxyphenyl)methoxy]methyl}tetrahydro-2-furanyl)-2-oxo-1,2-dihydro-4-pyrimidinyl]benzamide C44H51N3O9Si 详情 详情
(V) 61583 N-[1-((2R,3R,4R,5R)-3-{[tert-butyl(dimethyl)silyl]oxy}-4-hydroxy-5-{[tris(4-methoxyphenyl)methoxy]methyl}tetrahydro-2-furanyl)-2-oxo-1,2-dihydro-4-pyrimidinyl]benzamide C44H51N3O9Si 详情 详情
(VI) 61584 N-[1-((2R,3S,5R)-3-{[tert-butyl(dimethyl)silyl]oxy}-4-oxo-5-{[tris(4-methoxyphenyl)methoxy]methyl}tetrahydro-2-furanyl)-2-oxo-1,2-dihydro-4-pyrimidinyl]benzamide C44H49N3O9Si 详情 详情
(VII) 61585 N-{1-[(2R,3S,5R)-3-{[tert-butyl(dimethyl)silyl]oxy}-5-(hydroxymethyl)-4-oxotetrahydro-2-furanyl]-2-oxo-1,2-dihydro-4-pyrimidinyl}benzamide C22H29N3O6Si 详情 详情
(VIII) 23897 ethynyl(trimethyl)silane;trimethylsilyl acetylene 1066-54-2 C5H10Si 详情 详情
(IX) 61586 N-(1-{(2R,3R,4R,5R)-3-{[tert-butyl(dimethyl)silyl]oxy}-4-hydroxy-5-(hydroxymethyl)-4-[2-(trimethylsilyl)ethynyl]tetrahydro-2-furanyl}-2-oxo-1,2-dihydro-4-pyrimidinyl)benzamide C27H39N3O6Si2 详情 详情
(X) 61587 4-amino-1-{(2R,3R,4R,5R)-3-{[tert-butyl(dimethyl)silyl]oxy}-4-hydroxy-5-(hydroxymethyl)-4-[2-(trimethylsilyl)ethynyl]tetrahydro-2-furanyl}-2(1H)-pyrimidinone C20H35N3O5Si2 详情 详情

合成路线3

该中间体在本合成路线中的序号:(II)

Acylation of cytidine (I) with benzoic anhydride in DMF provides N4-benzoylcytidine (II), which is regioselectively protected at the 3’- and 5’-hydroxyl groups with 1,3-dichloro-1,1,3,3-tetraisopropyldisiloxane in pyridine, giving the cyclic siloxane derivative (III). Subsequent Swern oxidation of the 2’-alcohol group of compound (III) using DMSO, TFAA and Et3N followed by addition of methyllithium to the obtained ketone (IV) and desilylation with AcOH leads to the 2’-C-methylcytidine derivative (V). After reprotection of the primary and secondary hydroxyl groups of the cytidine (V) with benzoyl chloride in pyridine, the tertiary hydroxyl of compound (VI) is fluorinated using DAST in cold toluene to give the benzoyl-protected 2’-deoxy-2’-fluoro-2’-methylcytidine (VII) (1-3). In a different strategy, the nucleoside derivative (VII) is prepared by coupling of the methyl (VIIIa) (1-3) or acetyl (VIIIb) glycosides (4) or the glycosyl chloride (VIIIc) (5) with silylated N4-benzoylcytosine (IX) by means of either trimethylsilyl triflate or tin tetrachloride. The tribenzoylated precursor (VII) is then deprotected with methanolic NaOMe (1, 2) or ammonia (3, 4) to obtain PSI-6130 (X), which is finally esterified with isobutyryl chloride (XI) in the presence of DMAP and Et3N in THF/H2O (6). Scheme 1.

1 Clark, J. (Pharmasset Ltd.). Modified fluorinated nucleoside analogues. WO 2005003147.
2 Clark, J.L., Hollecker, L., Mason, J.C. Design, synthesis, and antiviral activity of 2’-deoxy-2’-fluoro-2’-C-methylcytidine, a potent inhibitor of hepatitis C virus replication. J Med Chem 2005, 48(17): 5504-8.
3 Clark, J. (Pharmasset, Inc.). Modified fluorinated nucleoside analogues. US 20080070861.
4 Chun, B.-K., Wang, P. (Pharmasset, Inc.). Preparation of 2’-fluoro-2’-alkyl-substituted or other optionally substituted ribofuranosyl pyrimidines and purines and their derivatives. WO 2006031725.
5 Axt, S.D., Sarma, K., Vitale, J. et al. (Pharmasset, Inc.; F. Hoffmann La Roche AG). Preparation of nucleosides ribofuranosyl pyrimidines. WO 2008045419.
6 Chun, B.-K., Clark, J., Sarma, K., Wang, P. (F. Hoffmann-La Roche AG; Pharmasset, Inc.). Antiviral nucleosides. WO 2007065829.
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(VIIIA) 65911 ((2S,3S,4S)-3-(benzoyloxy)-4-fluoro-5-methoxy-4-methyltetrahydrofuran-2-yl)methyl benzoate   C21H21FO6 详情 详情
(VIIIB) 65912     C22H21FO6 详情 详情
(VIIIC) 65913     C20H17ClFO5 详情 详情
(I) 27920 Cytidine; 4-amino-1-((2S,3S,4S,5S)-3,4-dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)pyrimidin-2(1H)-one;4-amino-1-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)tetrahydro-2-furanyl]-2(1H)-pyrimidinone 65-46-3 C9H13N3O5 详情 详情
(II) 61580 N-Benzoylcytidine;N-[1-[3,4-Dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-2-oxopyrimidin-4-yl]benzamide;N-{1-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)tetrahydro-2-furanyl]-2-oxo-1,2-dihydro-4-pyrimidinyl}benzamide 13089-48-0 C16H17N3O6 详情 详情
(III) 65906 N-Benzoyl-3',5'-O-[1,1,3,3-tetrakis(1-methylethyl)-1,3-disiloxanediyl]cytidine; N-[1-[(6aR,8R,9R,9aS)-9-hydroxy-2,2,4,4-tetra(propan-2-yl)-6a,8,9,9a-tetrahydro-6H-furo[3,2-f][1,3,5,2,4]trioxadisilocin-8-yl]-2-oxopyrimidin-4-yl]benzamide 69304-43-4 C28H43N3O7Si2 详情 详情
(IV) 65907 N-Benzoyl-2'-deoxy-2'-oxo-3',5'-O-[1,1,3,3-tetrakis(1-methylethyl)-1,3-disiloxanediyl]cytidine 119411-03-9 C28H41N3O7Si2 详情 详情
(V) 65908 N-Benzoyl-2'-C-methyl-D-cytidine   C17H19N3O6 详情 详情
(VI) 65909 N-Benzoyl-3',5'-di-O-benzoyl-2'-C-methyl-D-cytidine   C31H27N3O8 详情 详情
(VII) 65910 (2'R)-N-Benzoyl-2'-deoxy-2'-fluoro-2'-methylcytidine 3',5'-dibenzoate 817204-32-3 C31H26FN3O7 详情 详情
(IX) 12715 N-(2-Oxo-1,2-dihydro-4-pyrimidinyl)benzamide; N-Benzoylcytosine 26661-13-2 C11H9N3O2 详情 详情
(X) 65914 2'-Deoxy-2'-fluoro-2'-C-methylcytidine 817204-33-4 C10H14FN3O4 详情 详情
(XI) 14932 isobutyryl chloride; 2-methylpropanoyl chloride 79-30-1 C4H7ClO 详情 详情
Extended Information